| Muhammad Saim, MD | |
|
7777 Forest Ln Ste C335, Dallas, TX 75230-2544 | |
| (214) 328-2300 | |
| (214) 579-6989 |
| Full Name | Muhammad Saim |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 23 Years |
| Location | 7777 Forest Ln Ste C335, Dallas, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568673226 | NPI | - | NPPES |
| N9291 | Other | TX | MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | N9291 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Village Ii Dialysis Center | Dallas, TX | Dialysis facility |
| Medical City Dallas Hospital | Dallas, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dallas Nephrology Associates | 3870403819 | 128 |
News Archive
Colorectal cancer risk does not rise after bariatric surgery, a study from the University of Gothenburg shows. This finding is important for patients with obesity, and their healthcare professionals, when deciding upon such an operation.
BioSante Pharmaceuticals, Inc., announced today that the independent Data Monitoring Committee (DMC) has completed the seventh unblinded review of the LibiGel Phase III cardiovascular and breast cancer safety study, which has completed enrollment of subjects.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the U.S. and Europe, a drug that resolves tophi in less than one year would become the patient share leader in the chronic tophaceous gout patient subpopulation and would be used in the vast majority of patients who suffer severe tophaceous gout, according to surveyed U.S. and European rheumatologists.
Scientists in Britain say a dose of winter infections such flu can double the risk of heart attacks and strokes.
From December 13 - 14, 2010, the "Open Access - Open Data" Conference will be taking place in Cologne. It is an international expert conference that will look closely on how the Open Access movement has developed within the last five years and what is going to happen within the next five to ten years. Additionally, the "Open Data Movement" that is gaining more and more importance will be under consideration.
› Verified 7 days ago
| Entity Name | Dallas Nephrology Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861440109 PECOS PAC ID: 3870403819 Enrollment ID: O20040624000638 |
News Archive
Colorectal cancer risk does not rise after bariatric surgery, a study from the University of Gothenburg shows. This finding is important for patients with obesity, and their healthcare professionals, when deciding upon such an operation.
BioSante Pharmaceuticals, Inc., announced today that the independent Data Monitoring Committee (DMC) has completed the seventh unblinded review of the LibiGel Phase III cardiovascular and breast cancer safety study, which has completed enrollment of subjects.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the U.S. and Europe, a drug that resolves tophi in less than one year would become the patient share leader in the chronic tophaceous gout patient subpopulation and would be used in the vast majority of patients who suffer severe tophaceous gout, according to surveyed U.S. and European rheumatologists.
Scientists in Britain say a dose of winter infections such flu can double the risk of heart attacks and strokes.
From December 13 - 14, 2010, the "Open Access - Open Data" Conference will be taking place in Cologne. It is an international expert conference that will look closely on how the Open Access movement has developed within the last five years and what is going to happen within the next five to ten years. Additionally, the "Open Data Movement" that is gaining more and more importance will be under consideration.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Muhammad Saim, MD 1505 Lbj Fwy Ste 700, Dallas, TX 75234-6065 Ph: (214) 358-2300 | Muhammad Saim, MD 7777 Forest Ln Ste C335, Dallas, TX 75230-2544 Ph: (214) 328-2300 |
News Archive
Colorectal cancer risk does not rise after bariatric surgery, a study from the University of Gothenburg shows. This finding is important for patients with obesity, and their healthcare professionals, when deciding upon such an operation.
BioSante Pharmaceuticals, Inc., announced today that the independent Data Monitoring Committee (DMC) has completed the seventh unblinded review of the LibiGel Phase III cardiovascular and breast cancer safety study, which has completed enrollment of subjects.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the U.S. and Europe, a drug that resolves tophi in less than one year would become the patient share leader in the chronic tophaceous gout patient subpopulation and would be used in the vast majority of patients who suffer severe tophaceous gout, according to surveyed U.S. and European rheumatologists.
Scientists in Britain say a dose of winter infections such flu can double the risk of heart attacks and strokes.
From December 13 - 14, 2010, the "Open Access - Open Data" Conference will be taking place in Cologne. It is an international expert conference that will look closely on how the Open Access movement has developed within the last five years and what is going to happen within the next five to ten years. Additionally, the "Open Data Movement" that is gaining more and more importance will be under consideration.
› Verified 7 days ago
Uma B.r.k Pakkivenkata, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 215, Dallas, TX 75231 Phone: 214-396-4950 Fax: 877-423-5360 | |
Dr. Ariel Marcelo Modrykamien, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3600 Gaston Ave, Wadley Tower, Suite 960, Dallas, TX 75246 Phone: 402-972-6078 | |
Benjamin Seth Martinez, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-3111 Fax: 214-648-5461 | |
Vijaya Mummadi, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 225, Dallas, TX 75231 Phone: 469-646-8880 Fax: 469-646-8884 | |
Dr. Ting-yi Chen, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-2800 Fax: 214-645-2808 | |
William Cook Langmade, MD Nephrology Medicare: Medicare Enrolled Practice Location: 1441 N Beckley Ave, Dallas, TX 75203 Phone: 214-947-2306 | |
Dr. Janame J Kottey, MBBS Nephrology Medicare: Accepting Medicare Assignments Practice Location: 13154 Coit Rd Ste 100, Dallas, TX 75240 Phone: 214-358-2300 Fax: 214-579-6989 |